In the context of cancer, CD10 activity and its high expression has been correlated with a poor prognosis and decreased survival in a variety of malignancies, through mechanisms that include therapeutic drug and radiation resistance, increased tumor grade and a more aggressive phenotype (invasion and metastasis) (54–60). Here, MME is linked to cancer.